Hikma Pharmaceuticals PLC (HKMPF) Full Year 2025 Earnings Call Highlights: Strong EBITDA ... [Yahoo! Finance]
HIKMA PHARMS PLC S/ADR (HKMPY)
NASDAQ:AMEX Investor Relations:
hikma.com/en/investors.html
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus EBITDA Margins: 25%, outperforming competitors aiming for 22%. EBIT for Generic Business: GBP 100 million with margins close to 20%. R&D Budget: Targeting 5% to 6% of spending. Release Date: February 26, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Hikma Pharmaceuticals PLC ( HKMPF ) has consistently delivered growth with a strong track record, achieving a five-year CAGR and maintaining EBITDA margins of 25%, outperforming many competitors. The company is focusing on long-term growth by increasing its R&D budget to 5-6% of sales, aiming to drive innovation and future product launches. Hikma Pharmaceuticals PLC ( HKMPF ) is implementing a decentralized decision-making structure to empower employees and enhance agility across the organization. The company has a strong presence in the MENA region, being the number one company in the area, and continues
Show less
Read more
Impact Snapshot
Event Time:
HKMPY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HKMPY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HKMPY alerts
High impacting HIKMA PHARMS PLC S/ADR news events
Weekly update
A roundup of the hottest topics
HKMPY
News
- Hikma Pharma tumbles on softer guidance as buyback fails to soften pill [Yahoo! Finance]Yahoo! Finance
- Hikma Pharmaceuticals reports FY results [Seeking Alpha]Seeking Alpha
- Hikma Pharmaceuticals PLC (HKMPY) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Hikma Pharmaceuticals H2 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Hikma Pharmaceuticals gains amid takeover speculation [Seeking Alpha]Seeking Alpha